SIM-0348

N/A

Report date: 2022/12/29 10:17:52

Base Information

Drug NameSIM-0348

Drug Alias NameSIM-0348

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionAnti-T cell immunoglobulin and ITIM domainsTransmembrane protein PVRIG antagonists

TargetsT cell immunoglobulin and ITIM domainsTransmembrane protein PVRIG

Therapy Area/IndicationsSolid tumoursNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesSimcere Pharmaceutical Group Ltd

China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesJiangsu Simcere Pharmaceutical Co Ltd

Inactive CompaniesSimcere Pharmaceutical Group Ltd

Active IndicationsSolid tumours

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A